Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Mallamaci

Showing results (31-40 of 343) with videos related to

Pageof 35
Sort By:
Journal of the American Society of Nephrology : JASN|June 7, 2005
Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modelingGiovanni Tripepi, Francesca Mallamaci, Carmine Zoccali
Journal of the American Society of Nephrology : JASN|December 20, 2003
Novel cardiovascular risk factors in end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Seminars in Dialysis|November 10, 2007
It is important to lower homocysteine in dialysis patientsCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Seminars in Nephrology|November 22, 2005
Predictors of cardiovascular death in ESRDCarmine Zoccali, Giovanni Tripepi, Francesca Mallamaci
Journal of the American Society of Nephrology : JASN|November 30, 2006
Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?Carmine Zoccali, Giovanni Tripepi, Francesca Mallamaci
Current Opinion in Nephrology and Hypertension|February 16, 2008
Urotensin II: a cardiovascular and renal updateCarmine Zoccali, Zoccali Carmine, Francesca Mallamaci
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
Atherosclerosis in dialysis patients: does Chlamydia pneumoniae infection contribute to cardiovascular damage?Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Current Hypertension Reports|September 10, 2002
Hypertension as a cardiovascular risk factor in end-stage renal failureCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2022
Detecting and Treating Lung Congestion with Kidney FailureCarmine Zoccali, Francesca Mallamaci, Eugenio Picano
Blood Purification|February 15, 2021
Sleep Apnea as a Cardiorenal Risk Factor in CKD and Renal Transplant PatientsCarmine Zoccali, Stefanos Roumeliotis, Francesca Mallamaci
Pageof 35

Showing results (31-40 of 343) with videos related to

Sort By:
Pageof 35
Journal of the American Society of Nephrology : JASN|June 7, 2005
Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modelingGiovanni Tripepi, Francesca Mallamaci, Carmine Zoccali
Journal of the American Society of Nephrology : JASN|December 20, 2003
Novel cardiovascular risk factors in end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Seminars in Dialysis|November 10, 2007
It is important to lower homocysteine in dialysis patientsCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Seminars in Nephrology|November 22, 2005
Predictors of cardiovascular death in ESRDCarmine Zoccali, Giovanni Tripepi, Francesca Mallamaci
Journal of the American Society of Nephrology : JASN|November 30, 2006
Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?Carmine Zoccali, Giovanni Tripepi, Francesca Mallamaci
Current Opinion in Nephrology and Hypertension|February 16, 2008
Urotensin II: a cardiovascular and renal updateCarmine Zoccali, Zoccali Carmine, Francesca Mallamaci
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
Atherosclerosis in dialysis patients: does Chlamydia pneumoniae infection contribute to cardiovascular damage?Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Current Hypertension Reports|September 10, 2002
Hypertension as a cardiovascular risk factor in end-stage renal failureCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2022
Detecting and Treating Lung Congestion with Kidney FailureCarmine Zoccali, Francesca Mallamaci, Eugenio Picano
Blood Purification|February 15, 2021
Sleep Apnea as a Cardiorenal Risk Factor in CKD and Renal Transplant PatientsCarmine Zoccali, Stefanos Roumeliotis, Francesca Mallamaci
Pageof 35